MAM
MEDP icon

Martingale Asset Management’s Medpace MEDP Stock Holding History

Martingale Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
2,481
+548
+28% +$253K 0.03% 478
2026
Q1 		$928K Buy
+1,933
New +$990K 0.02% 517
2025
Q3 		– Sell
-1,231
Closed -$386K – 807
2025
Q2 		$386K Sell
1,231
-650
-35% -$195K 0.01% 663
2025
Q1 		$573K Hold
1,881
– – 0.01% 578
2024
Q4 		$625K Sell
1,881
-553
-23% -$188K 0.02% 569
2024
Q3 		$812K Sell
2,434
-1,600
-40% -$608K 0.02% 519
2024
Q2 		$1.66M Buy
4,034
+100
+3% +$39.6K 0.04% 344
2024
Q1 		$1.59M Buy
3,934
+209
+6% +$73.5K 0.03% 351
2023
Q4 		$1.14M Sell
3,725
-1,411
-27% -$381K 0.02% 425
2023
Q3 		$1.24M Sell
5,136
-1,118
-18% -$286K 0.03% 380
2023
Q2 		$1.5M Buy
6,254
+176
+3% +$36.6K 0.03% 336
2023
Q1 		$1.14M Buy
6,078
+370
+6% +$76.5K 0.02% 412
2022
Q4 		$1.21M Sell
5,708
-1,583
-22% -$316K 0.02% 404
2022
Q3 		$1.15M Buy
7,291
+231
+3% +$36.9K 0.02% 399
2022
Q2 		$1.06M Buy
7,060
+500
+8% +$72.4K 0.02% 446
2022
Q1 		$1.07M Sell
6,560
-1
-0% -$165 0.02% 467
2021
Q4 		$1.43M Sell
6,561
-800
-11% -$168K 0.02% 398
2021
Q3 		$1.4M Buy
7,361
+4,250
+137% +$775K 0.02% 418
2021
Q2 		$551K Sell
3,111
-200
-6% -$34.5K 0.01% 560
2021
Q1 		$544K Sell
3,311
-400
-11% -$61.2K 0.01% 583
2020
Q4 		$518K Sell
3,711
-15,400
-81% -$1.94M 0.01% 602
2020
Q3 		$2.14M Sell
19,111
-18,602
-49% -$2.15M 0.03% 398
2020
Q2 		$3.51M Buy
37,713
+8,105
+27% +$690K 0.04% 384
2020
Q1 		$2.17M Buy
+29,608
New +$2.57M 0.03% 467

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Martingale Asset Management's MEDP Position: Q2 2026 in Review

Martingale Asset Management increased its Medpace (MEDP) stake by 28% in Q2 2026, buying an estimated $253K and bringing the position to 2,481 shares worth $1.31M. The position accounts for 0.03% of the portfolio, ranked #478.

Martingale Asset Management first reported a position in MEDP in Q1 2020 and has held it in 24 quarters since. The position peaked at $3.51M in Q2 2020. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Martingale Asset Management held 2,481 shares of Medpace worth $1.31M as of Q2 2026.
  • Martingale Asset Management bought 548 Medpace shares in Q2 2026, an estimated $253K.
  • Medpace made up 0.03% of Martingale Asset Management's portfolio in Q2 2026, its #478 holding.
  • Martingale Asset Management first reported a position in Medpace in Q1 2020 and has held it in 24 quarters since.
  • Martingale Asset Management's Medpace position peaked at $3.51M in Q2 2020.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.